You can read the IBTA e-News May 2018 edition in full online here.
Some of the highlights from this month's monthly round-up:
- The official report of the IBTA’s Third Biennial World Summit of Brain Tumour Patient Advocates has been sent to IBTA mailing list members, will be distributed through various scientific conferences and events across the world, and is now available to read online here.
- In honour of the late Dame Tessa Jowell, the UK government has announced the £40 million “Tessa Jowell Brain Cancer Research Mission” which includes a boosted research fund, an annual global symposium and new commitments to clinical excellence.
- Researchers have identified a subtype of medulloblastoma brain tumours that is associated with improved survival of infants treated with less aggressive, 'risk-adapted' therapy.
- The Brain Tumour Charity (UK) is inviting applications for studies seeking to address the key quality of life issues faced by both adults and children with a brain tumour, as outlined in their two reports: “Losing Myself: The Reality of Life with a Brain Tumour” and “Losing My Place: The Reality of Childhood with a Brain Tumour”. The grants are up to £300,000 per project for up to three years and the deadline for applications is 3 September 2018.
- Work reported in the journal Nature Communications describes development of a new microfluidic device, the EVHB-Chip, that has the potential to replace invasive needle biopsies to identify tumour vulnerabilities, guide treatment decisions and monitor response.
- A team led by the Allen Institute for Brain Science and the Swedish Neuroscience Institute has established a resource called the Ivy Glioblastoma Atlas, which is an anatomy-based transcriptional atlas for glioblastoma that links to related genomic and clinical insights.
- The Children’s Brain Tumour Drug Delivery Consortium (CBTDDC) held their inaugural workshop on drug delivery to the brain on 4th May 2018. Over 50 delegates came together with the aim of advancing translational research in this field through multidisciplinary collaborations.
- The 2018 annual National Brain Tumor Society (NBTS) “Head to the Hill” advocacy event was held on 8 May. This year’s event rallied hundreds of brain tumour advocates from 38 states who travelled to Capitol Hill in Washington DC where volunteer brain tumour advocates and NBTS staff held more than 200 meetings with members of the US Congress and their aides to discuss the policy needs of brain tumour patients, survivors, and caregivers
- A case report and literature review published in World Neurosurgery describes a case of a complete meningioma regression in a postpartum patient. When a pregnant Californian woman was diagnosed with a brain tumour, doctors opted to delay treatment until after the birth. However, when she returned to hospital for a scan three months after the birth, her doctors found that the tumour had nearly disappeared.
Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 6,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.
To see an archive of existing e-News issues, click here.